Stemedica Cell Technologies, Inc., a leading manufacturer of adult allogeneic stem cells and stem cell factors announced that the Company has been issued U.S. Patent #8,318,485 by the United States Patent and Trademark Office.
http://www.prweb.com/releases/stemedica-stem-cells/diabetic-retinopathy/prweb10257473.htm
http://www.prweb.com/releases/stemedica-stem-cells/diabetic-retinopathy/prweb10257473.htm
No comments:
Post a Comment